AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (48)

Latest Posts

About This Stock More About This Stock
Citi Sees Advantage For Tesaro Despite Broad Lynparza Label
Article By: The Fly
Friday, August 18, 2017 6:00 AM EDT
Citi analyst Robyn Karnauskas says the "broad label" given yesterday to AstraZeneca's Lynparza increases competition for Tesaro.
In this article: AZN, TSRO Also: CLVS
Read
AstraZeneca Plunges Following Failed Lung Cancer Study
Article By: The Fly
Thursday, July 27, 2017 2:34 PM EDT
Shares of AstraZeneca are dropping sharply after the company said its MYSTIC trial failed to show its two-drug combination extended progression-free survival compared with standard-of-care chemotherapy for lung cancer patients.
In this article: AZN Also: MRK, TEVA, BMY
Read
AstraZeneca Says Phase III MYSTIC Trial Did Not Meet Primary Endpoint
Article By: The Fly
Thursday, July 27, 2017 7:29 AM EDT
The combination of Imfinzi and tremelimumab did not meet the primary endpoint of improving PFS compared to SoC in patients whose tumors express PD-L1 on 25% or more of their cancer cells.
In this article: AZN
Read
Three Large Cap Pharma Stocks To Buy Now
Article By: Zacks Investment Research
Wednesday, July 12, 2017 5:20 AM EDT
While investors might think that the uncertainty of health care reform would bring volatility into the sector, we’ve actually seen healthcare stocks have a pretty decent year so far. The overall “Medical” sector is up about 11.9% year-to-date.
In this article: AZN, BAYRY, HLUYY
Read
Hot Options Report: End Of Day - Monday, July 10
Article By: The Options Insider
Monday, July 10, 2017 10:29 PM EDT
Most active stock options for end of day Monday: BAC, ASH, X, CSX, ICE, AAPL, CBI, NVDA and AZN.
In this article: ASH, AZN, BAC, CBI, CSX, ICE, X, AAPL, NVDA
Read

PARTNER HEADLINES

Latest Tweets for $AZN

No tweets yet!